MSI-H CANCER

Clinical trials for MSI-H CANCER explained in plain language.

Never miss a new study

Get alerted when new MSI-H CANCER trials appear

Sign up with your email to follow new studies for MSI-H CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet finished but already full! 1 Completed 1

Cancer drug danger? new study probes heart risks of immunotherapy

Knowledge-focused Completed

This study looked at how immune checkpoint inhibitors, a type of cancer drug, might harm blood vessels and speed up artery disease. Researchers followed 39 cancer patients before and after starting these drugs, using ultrasound and blood tests to track changes. The goal was to be…

Matched conditions: MSI-H CANCER

Phase: NA • Sponsor: Institut Mutualiste Montsouris • Aim: Knowledge-focused

Last updated May 14, 2026 12:06 UTC

MSI-H CANCER

Get alerted when new MSI-H CANCER trials appear

Cancer drug danger? new study probes heart risks of immunotherapy